Rankings
▼
Calendar
ELVN FY 2018 Earnings — Enliven Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ELVN
Enliven Therapeutics, Inc.
$2B
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$11M
Net Income
-$11M
EPS (Diluted)
$-2.62
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$555,000
Balance Sheet
Total Assets
$8M
Total Liabilities
$2M
Stockholders' Equity
-$26M
Cash & Equivalents
$7M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$11M
-$9M
-19.9%
Net Income
-$11M
$0
—
← FY 2017
All Quarters
Q1 2019 →